Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Taysha Gene Therapies, Inc.

2.18
+0.07503.57%
Volume:510.44K
Turnover:1.11M
Market Cap:445.99M
PE:-6.09
High:2.22
Open:2.09
Low:2.07
Close:2.10
Loading ...
OverviewCompanyNewsFilings

Piper Sandler Releases a Buy Rating on Taysha Gene Therapies (TSHA)

TIPRANKS
·
12 Nov 2024

Taysha Gene Therapies Price Target Maintained With a $6.00/Share by Needham

Dow Jones
·
12 Nov 2024

Taysha Gene Therapies Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
12 Nov 2024

Promising Developments in Taysha Gene Therapies’ MECP2 Treatment Boost Analyst’s Positive Outlook

TIPRANKS
·
12 Nov 2024

US Penny Stocks To Watch In November 2024

Simply Wall St.
·
12 Nov 2024

Neurogene plummets 35% on gene therapy trial data for Rett syndrome

seekingalpha
·
12 Nov 2024

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
May 15, 2025 Pre-Market
Financial Report Announcement
Feb 26, 2025 Pre-Market
Financial Report Announcement
Nov 13, 2024 Post Market
Financial Report Announcement
Aug 12, 2024 Pre-Market
Financial Report Announcement
May 14, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-4.36
Current
-23.75
Sector Average
37.78%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-4.36
Maximum
-0.26
+1 STD
36.03
Minimum
-260.86
-1 STD
-83.52
Average
-23.75

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.